I almost fell for a scammer. This one rule saved me — and could help you, too.
Scams are sophisticated and come in many shapes and forms. It’s easy to be fooled.
Wine and Stocks Thoughts about wine and stocks
An adviser told me I can save 35% of the taxes on a Roth conversion. Is that true?
The age-old rule applies: If it sounds too good to be true, it probably is.
I inherited a house. My CPA says I should sell within a year to avoid capital gains. Is he right?
“We plan to sell it to another family member for the appraised value.”
These underdogs are a big reason S&P 500 profit growth is the fastest in nearly 5 years
Ever since Big Tech went all in on artificial intelligence more than three years ago, seven companies have done the heavy lifting for overall S&P 500 earnings growth. But more recently, the other 493 names in the index have started to pull their weight.
Stocks are riding an earnings hot streak — but investors are facing a summer that’s rife with risks
The U.S. stock market has arrived at the unofficial start to summer with major benchmarks sitting at record highs. But a few factors could make for a bumpy ride in the months ahead.
‘We have longevity in the family’: My sister is turning 67. Should she wait until 70 to claim Social Security?
“Others say she should start at full retirement age.”
The bond market just flipped the script on investors — Wall Street is acting like nothing’s wrong
When credit and stocks disagree, credit is the one telling the truth.
Annuity payouts are the highest they’ve been in years. Thanks, inflation.
A silver lining to the cloud of high interest rates.
As bullish bets surge, here’s the Goldman Sachs options play to protect portfolios from the likely pullback
Materials, tech and energy sectors offer an attractive hedging opportunity
Canada and India now have generic Wegovy. Here’s why the U.S. doesn’t.
Over the next year, countries that are home to 40% of the world’s population are set to get access to Ozempic and Wegovy generics that could cost as little as $15 a month.
